IMUX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | 2023 | Dr. Daniel Vitt Chief Executive Officer, President | 585,042 | 0 | 0 | 284,917 | 0 | 1,211,839 |
| 2024-04-23 | 2022 | Glenn Whaley Chief Financial Officer | 401,700 | 0 | 0 | 120,510 | 0 | 1,476,010 |
| 2024-04-23 | 2023 | Glenn Whaley Chief Financial Officer | 415,000 | 0 | 0 | 161,850 | 0 | 702,206 |
| 2024-04-23 | 2022 | Dr. Andreas Muehler Chief Medical Officer | 445,875 | 0 | 0 | 137,912 | 15,786 | 1,464,733 |
| 2024-04-23 | 2023 | Dr. Andreas Muehler Chief Medical Officer | 493,030 | 0 | 0 | 185,748 | 16,085 | 845,290 |
| 2024-04-23 | 2022 | Dr. Duane Nash Executive Chairman | 347,403 | 0 | 0 | 86,000 | 0 | 1,068,590 |
| 2024-04-23 | 2023 | Dr. Duane Nash Executive Chairman | 363,000 | 0 | 0 | 141,570 | 0 | 648,925 |
| 2024-04-23 | 2022 | Dr. Daniel Vitt Chief Executive Officer, President | 519,574 | 0 | 0 | 208,829 | 0 | 2,557,171 |
| 2023-05-01 | 2021 | Glenn Whaley Chief Financial Officer | 343,333 | 0 | 0 | 105,146 | 0 | 928,331 |
| 2023-05-01 | 2022 | Glenn Whaley Chief Financial Officer | 401,700 | 0 | 0 | 120,510 | 0 | 1,476,010 |
| 2023-05-01 | 2021 | Dr. Andreas Muehler Chief Medical Officer | 378,455 | 0 | 0 | 115,902 | 17,640 | 1,291,756 |
| 2023-05-01 | 2022 | Dr. Andreas Muehler Chief Medical Officer | 445,875 | 0 | 0 | 137,912 | 15,786 | 1,464,733 |
| 2023-05-01 | 2021 | Dr. Duane Nash Executive Chairman | 326,619 | 0 | 0 | 100,000 | 0 | 1,407,137 |
| 2023-05-01 | 2022 | Dr. Duane Nash Executive Chairman | 347,403 | 0 | 0 | 86,000 | 0 | 1,068,590 |
| 2023-05-01 | 2021 | Dr. Daniel Vitt Chief Executive Officer, President | 399,168 | 0 | 0 | 157,172 | 0 | 1,935,915 |
| 2023-05-01 | 2022 | Dr. Daniel Vitt Chief Executive Officer, President | 519,574 | 0 | 0 | 208,829 | 0 | 2,557,171 |
| 2022-04-27 | 2021 | Dr. Daniel Vitt Chief Executive Officer, President | 446,040 | 0 | 0 | 175,628 | 0 | 2,001,243 |
| 2022-04-27 | 2021 | Dr. Andreas Muehler Chief Medical Officer | 398,506 | 0 | 0 | 122,042 | 17,640 | 1,317,948 |
| 2022-04-27 | 2020 | Dr. Andreas Muehler Chief Medical Officer | 358,203 | 0 | 0 | 169,027 | 17,789 | 934,748 |
| 2022-04-27 | 2021 | Glenn Whaley Chief Financial Officer | 343,333 | 0 | 0 | 105,146 | 0 | 928,331 |
| 2022-04-27 | 2020 | Glenn Whaley Chief Financial Officer | 310,833 | 0 | 0 | 177,345 | 0 | 848,288 |
| 2022-04-27 | 2020 | Dr. Daniel Vitt Chief Executive Officer, President | 380,909 | 0 | 0 | 228,545 | 0 | 1,318,054 |
| 2022-04-27 | 2021 | Dr. Duane Nash Executive Chairman | 326,619 | 0 | 0 | 100,000 | 0 | 1,407,137 |
| 2022-04-27 | 2020 | Dr. Duane Nash Executive Chairman | 214,889 | 0 | 0 | 131,500 | 16,250 | 2,199,796 |
| 2021-04-27 | 2020 | Dr. Duane Nash Executive Chairman | 231,139 | 0 | 0 | 131,500 | 0 | 2,199,796 |
| 2021-04-27 | 2020 | Dr. Daniel Vitt Chief Executive Officer, President | 380,909 | 0 | 0 | 228,545 | 0 | 1,318,054 |
| 2021-04-27 | 2019 | Dr. Daniel Vitt Chief Executive Officer, President | 202,275 | 0 | 1,495,870 | 111,986 | 0 | 2,383,932 |
| 2021-04-27 | 2019 | Dr. Duane Nash Executive Chairman | 43,850 | 0 | 0 | 0 | 0 | 308,650 |
| 2021-04-27 | 2020 | Dr. Andreas Muehler Chief Medical Officer | 358,203 | 0 | 0 | 169,027 | 17,789 | 934,748 |
| 2021-04-27 | 2019 | Dr. Andreas Muehler Chief Medical Officer | 177,772 | 0 | 1,495,870 | 79,434 | 11,858 | 2,118,072 |
| 2021-04-27 | 2020 | Glenn Whaley Principal Financial and Accounting Officer | 310,833 | 0 | 0 | 177,345 | 0 | 848,288 |
| 2021-04-27 | 2019 | Glenn Whaley Principal Financial and Accounting Officer | 24,583 | 0 | 0 | 0 | 0 | 98,701 |
| 2020-04-29 | 2019 | Dr. Andreas Muehler Chief Medical Officer | 177,772 | 0 | 1,495,870 | 79,434 | 11,858 | 2,118,072 |
| 2020-04-29 | 2018 | Dr. Andreas Muehler Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | Russell J. Cox Former Chief Executive Officer | 5,711 | 0 | 468,045 | 202,134 | 540,000 | 1,215,890 |
| 2020-04-29 | 2018 | Russell J. Cox Former Chief Executive Officer | 572,626 | 0 | 0 | 330,000 | 73,433 | 8,056,689 |
| 2020-04-29 | 2019 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer | 120,983 | 0 | 223,706 | 165,920 | 188,789 | 964,198 |
| 2020-04-29 | 2018 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer | 414,800 | 0 | 0 | 0 | 43,615 | 753,152 |
| 2020-04-29 | 2019 | Dr. Daniel Vitt Chief Executive Officer, President | 202,275 | 0 | 1,495,870 | 111,986 | 0 | 2,383,932 |
| 2020-04-29 | 2018 | Dr. Daniel Vitt Chief Executive Officer, President | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | Dr. Manfred Gröppel Chief Operating Officer | 137,649 | 0 | 1,495,870 | 55,993 | 0 | 1,866,067 |
| 2020-04-29 | 2018 | Dr. Manfred Gröppel Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019-06-18 | 2017 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer and President | 400,000 | 0 | 0 | 177,496 | 0 | 771,143 |
| 2019-06-18 | 2018 | Russell J. Cox Former Chief Executive Officer | 572,626 | 0 | 0 | 330,000 | 73,433 | 8,056,689 |
| 2019-06-18 | 2017 | Russell J. Cox Former Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019-06-18 | 2018 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer and President | 414,800 | 0 | 0 | 0 | 43,615 | 753,152 |
| 2019-06-18 | 2018 | Robert A. Ashley, M.A. Former Executive Vice President and Chief Scientific Officer | 396,344 | 0 | 0 | 0 | 47,769 | 704,175 |
| 2019-06-18 | 2017 | Robert A. Ashley, M.A. Former Executive Vice President and Chief Scientific Officer | 381,000 | 0 | 0 | 158,200 | 0 | 710,065 |
| 2018-04-12 | 2016 | Duane D. Nash, M.D., J.D. President | 375,550 | 0 | 0 | 67,820 | 0 | 941,810 |
| 2018-04-12 | 2017 | Duane D. Nash, M.D., J.D. President | 400,000 | 0 | 0 | 177,496 | 0 | 771,143 |
| 2018-04-12 | 2016 | Terence E. Winters, Ph.D. Chief Executive Officer | 490,000 | 0 | 0 | 73,500 | 18,808 | 1,168,708 |
| 2018-04-12 | 2017 | Terence E. Winters, Ph.D. Chief Executive Officer | 504,700 | 0 | 0 | 219,746 | 550,551 | 2,177,167 |
| 2018-04-12 | 2016 | Robert A. Ashley Executive Vice President and Chief Technical | 370,000 | 0 | 0 | 83,528 | 0 | 893,328 |
| 2018-04-12 | 2017 | Robert A. Ashley Executive Vice President and Chief Technical | 381,100 | 0 | 0 | 158,200 | 0 | 710,165 |
| 2017-04-11 | 2016 | Duane D. Nash, M.D., J.D. President | 375,550 | 0 | 0 | 67,820 | 0 | 941,810 |
| 2017-04-11 | 2015 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive | 469,896 | 0 | 0 | 100,000 | 17,397 | 883,853 |
| 2017-04-11 | 2016 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive | 490,000 | 0 | 0 | 73,500 | 18,808 | 1,168,708 |
| 2017-04-11 | 2015 | Robert A. Ashley Executive Vice President and Chief | 357,958 | 0 | 0 | 78,000 | 0 | 658,378 |
| 2017-04-11 | 2016 | Robert A. Ashley Executive Vice President and Chief | 370,000 | 0 | 0 | 83,528 | 0 | 893,328 |
| 2017-04-11 | 2015 | Duane D. Nash, M.D., J.D. President | 357,958 | 0 | 0 | 78,000 | 0 | 658,378 |
| 2016-04-14 | 2014 | Duane D. Nash, M.D. President | 350,000 | 0 | 0 | 100,030 | 0 | 450,030 |
| 2016-04-14 | 2014 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 450,000 | 0 | 0 | 171,900 | 16,010 | 637,910 |
| 2016-04-14 | 2015 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 469,896 | 0 | 0 | 100,000 | 17,397 | 883,853 |
| 2016-04-14 | 2015 | Robert A. Ashley | 357,958 | 0 | 0 | 78,000 | 0 | 658,378 |
| 2016-04-14 | 2015 | Duane D. Nash, M.D. President | 357,958 | 0 | 0 | 78,000 | 0 | 658,378 |
| 2015-10-07 | 2014 | John M. Dunn, J.D. | 35,625 | 0 | 0 | 0 | 0 | 700,745 |
| 2015-10-07 | 2013 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 418,125 | 0 | 0 | 110,719 | 16,104 | 544,948 |
| 2015-10-07 | 2014 | Duane D. Nash, M.D., J.D. | 350,000 | 0 | 0 | 100,030 | 0 | 450,030 |
| 2015-10-07 | 2014 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 450,000 | 0 | 0 | 171,900 | 16,010 | 637,910 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
